Abbas Jafari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Abbas Jafari has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Abdollahi
Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
5 shared publications - Amir Baghaei
Department of Toxicology and Pharmacology, Faculty of Pharmacy, Alborz University of Medical Sciences, Karaj, Iran
4 shared publications Reza Solgi
Legal Medicine Research Center, Legal Medicine Organization of Iran, Hamedan, Iran
4 shared publications- Shokoufeh Hassani
Toxicology and Diseases Group (TDG), Pharmaceutical Sciences ResearchCenter (PSRC), Tehran University of Medical Sciences (TUMS), Tehran, Iran
4 shared publications - Mahmoud Ghazi-Khansari
Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3 shared publications - Maryam Baeeri
Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran
3 shared publications
Latest Publications
- 17 May 2023
- Published by Springer Nature in Environmental Geochemistry and Health
- Vol. 45 (8) , 5961-5979
Monte Carlo-based probabilistic risk assessment for cement workers exposed to heavy metals in cement dust
This study assessed the carcinogenic and non-carcinogenic health risks of cement plant workers exposed to chromium (Cr), arsenic (As), cadmium (Cd), and lead (Pb) in cement dust using a probabilistic approach. Air samples were collected according to NIOSH 7900 and OSHA ID-121 methods and analyzed by an graphite furnace atomic absorption spectrometer. The EPA inhalation risk assessment model and Monte Carlo simulation were utilized to assess the health risks. Sensitivity analysis was used to determine the influencing parameters on health risk. The average concentrations of As and Pb exceeded the occupational exposure limit (OEL), reaching a maximum of 3.4 and 1.7 times the OEL, respectively, in the cement mill. Individual metals' cancer risk exceeded the 1E–4 threshold in ascending order of Cd < As < Cr. The mean cancer risk of Cr ranged from 835E-4 (in raw mill) to 2870E-4 (in pre-heater and kiln). Except for Cd, the non-cancer risk of metals exceeded the standard (hazard index, HQ = 1) in the ascending order of Pb < As < Cr. The mean HQ of Cr ranged from 162.13 (in raw mill) to 558.73 (in pre-heater and kiln). After adjusting for control factors, the cancer and non-cancer risks remained over the respective recommended levels. Sensitivity analysis revealed that the concentration of Cr was the most influential parameter on both carcinogenic (78.5%) and non-carcinogenic (88.06%) risks. To protect the health of cement factory employees, it is recommended to minimize cement dust emissions, implement job rotation, and use raw materials with low levels of heavy metals.
- 17 May 2023
- Published by Springer Nature in Environmental Geochemistry and Health
- Vol. 45 (8) , 5961-5979
Monte Carlo-based probabilistic risk assessment for cement workers exposed to heavy metals in cement dust
This study assessed the carcinogenic and non-carcinogenic health risks of cement plant workers exposed to chromium (Cr), arsenic (As), cadmium (Cd), and lead (Pb) in cement dust using a probabilistic approach. Air samples were collected according to NIOSH 7900 and OSHA ID-121 methods and analyzed by an graphite furnace atomic absorption spectrometer. The EPA inhalation risk assessment model and Monte Carlo simulation were utilized to assess the health risks. Sensitivity analysis was used to determine the influencing parameters on health risk. The average concentrations of As and Pb exceeded the occupational exposure limit (OEL), reaching a maximum of 3.4 and 1.7 times the OEL, respectively, in the cement mill. Individual metals' cancer risk exceeded the 1E–4 threshold in ascending order of Cd < As < Cr. The mean cancer risk of Cr ranged from 835E-4 (in raw mill) to 2870E-4 (in pre-heater and kiln). Except for Cd, the non-cancer risk of metals exceeded the standard (hazard index, HQ = 1) in the ascending order of Pb < As < Cr. The mean HQ of Cr ranged from 162.13 (in raw mill) to 558.73 (in pre-heater and kiln). After adjusting for control factors, the cancer and non-cancer risks remained over the respective recommended levels. Sensitivity analysis revealed that the concentration of Cr was the most influential parameter on both carcinogenic (78.5%) and non-carcinogenic (88.06%) risks. To protect the health of cement factory employees, it is recommended to minimize cement dust emissions, implement job rotation, and use raw materials with low levels of heavy metals.
- 17 June 2022
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 46 (5) , 2548-2555
The Promising Effect of Topiramate on Random-Pattern Skin Flap Survival in Rats
Background Partial necrosis of skin flaps following plastic and reconstructive surgeries is one of the major problems in these medical interventions. This study was conducted to evaluate the beneficial effects of topiramate an anti-epileptic agent on ischemic random skin flaps. Materials and Methods Twenty-four Wistar rats were provided and randomly divided into four experimental groups (control group and low-, intermediate- and high-dose treatment groups). A rat random-pattern skin flap model was performed in all groups, and animals in the low-, intermediate- and high-dose experimental groups were administered topiramate intraperitoneally at doses of 25, 50 and 100 mg/kg, respectively, 1 h before raising the flap and once daily for 7 consecutive days after the initial surgical procedure. Control rats received vehicle according to the same schedule. On postoperative day 7 the flap necrotic area was measured, and tissue samples were stained with hematoxylin and eosin for histological analysis. Furthermore, the oxidative stress in flap tissue was assessed by measuring the activity of superoxide dismutase (SOD), glutathione (GSH) level and the content of malondialdehyde (MDA). Results Treating animals with 50 and 100 mg/kg topiramate significantly decreased the necrotic flap areas as compared to the control group. Histological studies demonstrated that in intermediate and high dose topiramate groups the inflammatory cell numbers were attenuated and microvessel development were markedly increased. Furthermore, the MDA contents were significantly reduced and GSH levels were significantly increased in these groups as compared to the control group. However, the SOD activity was increased significantly only in high-dose group as compared to the control group. Conclusions These findings indicated that topiramate in doses of 50 and 100 mg/kg increases random skin flap survival. No Level Assigned This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 17 June 2022
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 46 (5) , 2548-2555
The Promising Effect of Topiramate on Random-Pattern Skin Flap Survival in Rats
Background Partial necrosis of skin flaps following plastic and reconstructive surgeries is one of the major problems in these medical interventions. This study was conducted to evaluate the beneficial effects of topiramate an anti-epileptic agent on ischemic random skin flaps. Materials and Methods Twenty-four Wistar rats were provided and randomly divided into four experimental groups (control group and low-, intermediate- and high-dose treatment groups). A rat random-pattern skin flap model was performed in all groups, and animals in the low-, intermediate- and high-dose experimental groups were administered topiramate intraperitoneally at doses of 25, 50 and 100 mg/kg, respectively, 1 h before raising the flap and once daily for 7 consecutive days after the initial surgical procedure. Control rats received vehicle according to the same schedule. On postoperative day 7 the flap necrotic area was measured, and tissue samples were stained with hematoxylin and eosin for histological analysis. Furthermore, the oxidative stress in flap tissue was assessed by measuring the activity of superoxide dismutase (SOD), glutathione (GSH) level and the content of malondialdehyde (MDA). Results Treating animals with 50 and 100 mg/kg topiramate significantly decreased the necrotic flap areas as compared to the control group. Histological studies demonstrated that in intermediate and high dose topiramate groups the inflammatory cell numbers were attenuated and microvessel development were markedly increased. Furthermore, the MDA contents were significantly reduced and GSH levels were significantly increased in these groups as compared to the control group. However, the SOD activity was increased significantly only in high-dose group as compared to the control group. Conclusions These findings indicated that topiramate in doses of 50 and 100 mg/kg increases random skin flap survival. No Level Assigned This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 18 March 2022
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 130 (5) , 559-568
Gastroprotective effect of topiramate on indomethacin‐induced peptic ulcer in rats: Biochemical and histological analyses
Topiramate is an anticonvulsant drug effective against a wide range of seizures and epilepsies. The present study was conducted to investigate the possible protective effect of topiramate on indomethacin‐induced gastric mucosal damage in rats. The animals were randomly distributed into four experimental groups with 10 animals in each group. Group 1 was the control group received vehicle only (DMSO at 1:4 (w/v)), group 2 was the model group received indomethacin (50 mg/kg; i.p.), and groups 3 and 4 received topiramate (100 mg/kg; i.p.) and ranitidine (100 mg/kg; i.p.), respectively, 1 h before indomethacin (50 mg/kg; i.p.). The efficacy of topiramate was compared with ranitidine. Animals were euthanized 4 h after indomethacin administration, and gastric tissues were collected for macroscopical, histopathological, and biochemical analyses. The mucosal lesions in the gastric corpus were evaluated by pathological examinations. The results revealed that the administration of indomethacin caused evident gastric mucosal damage with morphological and histological manifestation, whereas topiramate pretreatment extensively ameliorated the gastric injuries. Topiramate pretreatment also reduced the contents of tissue malonaldehyde, enhanced ferric reducing antioxidant power value and glutathione levels, and increased the activity of superoxide dismutase, catalase, and glutathione peroxidase in gastric mucosa compared to the model group. Our results indicate that topiramate might possess a protective role against indomethacin‐induced gastric ulcers by inhibition of oxidative stress in gastric tissue.
- 18 March 2022
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 130 (5) , 559-568
Gastroprotective effect of topiramate on indomethacin‐induced peptic ulcer in rats: Biochemical and histological analyses
Topiramate is an anticonvulsant drug effective against a wide range of seizures and epilepsies. The present study was conducted to investigate the possible protective effect of topiramate on indomethacin‐induced gastric mucosal damage in rats. The animals were randomly distributed into four experimental groups with 10 animals in each group. Group 1 was the control group received vehicle only (DMSO at 1:4 (w/v)), group 2 was the model group received indomethacin (50 mg/kg; i.p.), and groups 3 and 4 received topiramate (100 mg/kg; i.p.) and ranitidine (100 mg/kg; i.p.), respectively, 1 h before indomethacin (50 mg/kg; i.p.). The efficacy of topiramate was compared with ranitidine. Animals were euthanized 4 h after indomethacin administration, and gastric tissues were collected for macroscopical, histopathological, and biochemical analyses. The mucosal lesions in the gastric corpus were evaluated by pathological examinations. The results revealed that the administration of indomethacin caused evident gastric mucosal damage with morphological and histological manifestation, whereas topiramate pretreatment extensively ameliorated the gastric injuries. Topiramate pretreatment also reduced the contents of tissue malonaldehyde, enhanced ferric reducing antioxidant power value and glutathione levels, and increased the activity of superoxide dismutase, catalase, and glutathione peroxidase in gastric mucosa compared to the model group. Our results indicate that topiramate might possess a protective role against indomethacin‐induced gastric ulcers by inhibition of oxidative stress in gastric tissue.
- Open Access
- 1 March 2022
- Published by CMV Verlag in Studies in Medical Sciences
- Vol. 32 (12) , 908-918
EVALUATION OF EXPOSURE TO FLOUR DUST AND RESPIRATORY COMPLICATIONS IN BAKERY WORKERS IN URMIA IN 2021
- 1 March 2022
- Published by CMV Verlag in Studies in Medical Sciences
- Vol. 32 (12) , 908-918
Open AccessEVALUATION OF EXPOSURE TO FLOUR DUST AND RESPIRATORY COMPLICATIONS IN BAKERY WORKERS IN URMIA IN 2021
- Open Access
- 1 December 2021
- Published by CMV Verlag in Studies in Medical Sciences
- Vol. 32 (9) , 707-714
EVALUATION OF THE PRESCRIPTION PATTERN AND DRUG INTERACTIONS OF NON-STREOIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS REFERRED TO TALEGHANI AND IMAM KHOMEINI EDUCATIONAL PHARMACIES IN URMIA IN THE FIRST 6 MONTHS OF 2019
- 1 December 2021
- Published by CMV Verlag in Studies in Medical Sciences
- Vol. 32 (9) , 707-714
Open AccessEVALUATION OF THE PRESCRIPTION PATTERN AND DRUG INTERACTIONS OF NON-STREOIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS REFERRED TO TALEGHANI AND IMAM KHOMEINI EDUCATIONAL PHARMACIES IN URMIA IN THE FIRST 6 MONTHS OF 2019
- Open Access
- 1 February 2021
- Published by CMV Verlag in Military Caring Sciences
- Vol. 7 (4) , 340-350
Comparison of the Impact of Training Through Workshop and Training Through online learning on Knowledge, Attitude and Performance of Emergency Nurses of Selected Hospitals of Aja about Safe Injections
Introduction: Safe injection as a part of the quality and safe care, is one of the common methods of prescribing drugs. If safety standards are not observed, recipients and service providers may face many risks.. Objective: The present study aims to compare the effect of training through a workshop and training through ...
- 1 February 2021
- Published by CMV Verlag in Military Caring Sciences
- Vol. 7 (4) , 340-350
Open AccessComparison of the Impact of Training Through Workshop and Training Through online learning on Knowledge, Attitude and Performance of Emergency Nurses of Selected Hospitals of Aja about Safe Injections
Introduction: Safe injection as a part of the quality and safe care, is one of the common methods of prescribing drugs. If safety standards are not observed, recipients and service providers may face many risks.. Objective: The present study aims to compare the effect of training through a workshop and training through ...
- 1 February 2021
- Published by Elsevier in Chemosphere
- Vol. 264, 128464
Neurological effects of long-term exposure to low doses of pesticides mixtures in male rats: Biochemical, histological, and neurobehavioral evaluations
- 1 February 2021
- Published by Elsevier in Chemosphere
- Vol. 264, 128464
Neurological effects of long-term exposure to low doses of pesticides mixtures in male rats: Biochemical, histological, and neurobehavioral evaluations
- Open Access
- 18 January 2021
- Published by Springer Nature in Systematic Reviews
- Vol. 10 (1) , 1-8
Endectocides as a complementary intervention in the malaria control program: a systematic review
Background: Malaria is the most common vector-borne disease transmitted to humans by Anopheles mosquitoes. Endectocides and especially ivermectin will be available as a vector control tool soon. The current review could be valuable for trial design and clinical studies to control malaria transmission. Methods: PubMed/MEDLINE, Scopus, Web of Science, and Science Direct were searched for original English published papers on (“Malaria chemical control” OR “Malaria elimination” OR “Anopheles vector control” OR “Malaria zooprophylaxis”) AND (“Systemic insecticides” OR “Endectocides” OR “Ivermectin”). The last search was from 19 June 2019 to 31 December 2019. It was updated on 17 November 2020. Two reviewers (SG and FGK) independently reviewed abstracts and full-text articles. Data were extracted by one person and checked by another. As meta-analyses were not possible, a qualitative summary of results was performed. Results: Thirty-six published papers have used systemic insecticides/endectocides for mosquito control. Most of the studies (56.75%) were done on Anopheles gambiae complex species on doses from 150 μg/kg to 400 μg/kg in several studies. Target hosts for employing systemic insecticides/drugs were animals (44.2%, including rabbit, cattle, pig, and livestock) and humans (32.35%). Conclusions: Laboratory and field studies have highlighted the potential of endectocides in malaria control. Ivermectin and other endectocides could soon serve as novel malaria transmission control tools by reducing the longevity of Anopheles mosquitoes that feed on treated hosts, potentially decreasing Plasmodium parasite transmission when used as mass drug administration (MDA).
- 18 January 2021
- Published by Springer Nature in Systematic Reviews
- Vol. 10 (1) , 1-8
Open AccessEndectocides as a complementary intervention in the malaria control program: a systematic review
Background: Malaria is the most common vector-borne disease transmitted to humans by Anopheles mosquitoes. Endectocides and especially ivermectin will be available as a vector control tool soon. The current review could be valuable for trial design and clinical studies to control malaria transmission. Methods: PubMed/MEDLINE, Scopus, Web of Science, and Science Direct were searched for original English published papers on (“Malaria chemical control” OR “Malaria elimination” OR “Anopheles vector control” OR “Malaria zooprophylaxis”) AND (“Systemic insecticides” OR “Endectocides” OR “Ivermectin”). The last search was from 19 June 2019 to 31 December 2019. It was updated on 17 November 2020. Two reviewers (SG and FGK) independently reviewed abstracts and full-text articles. Data were extracted by one person and checked by another. As meta-analyses were not possible, a qualitative summary of results was performed. Results: Thirty-six published papers have used systemic insecticides/endectocides for mosquito control. Most of the studies (56.75%) were done on Anopheles gambiae complex species on doses from 150 μg/kg to 400 μg/kg in several studies. Target hosts for employing systemic insecticides/drugs were animals (44.2%, including rabbit, cattle, pig, and livestock) and humans (32.35%). Conclusions: Laboratory and field studies have highlighted the potential of endectocides in malaria control. Ivermectin and other endectocides could soon serve as novel malaria transmission control tools by reducing the longevity of Anopheles mosquitoes that feed on treated hosts, potentially decreasing Plasmodium parasite transmission when used as mass drug administration (MDA).
- Open Access
- 1 December 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 132, 110859
Innate and adaptive immune responses against coronavirus
- 1 December 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 132, 110859
Open AccessInnate and adaptive immune responses against coronavirus
- 2 October 2019
- Published by Taylor & Francis in Food Reviews International
- Vol. 36 (7) , 692-712
Occurrence of Aflatoxin M1 in Milks of Five Animal Species in Iran: A Systematic Review and Meta-analysis
- 2 October 2019
- Published by Taylor & Francis in Food Reviews International
- Vol. 36 (7) , 692-712
Occurrence of Aflatoxin M1 in Milks of Five Animal Species in Iran: A Systematic Review and Meta-analysis